Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 6Genitourinary 4Gynecologic 1Dermatologic 1

Conditions

Prostatic Neoplasms 4

Interventions

pembrolizumab 182Magnetic Resonance Spectroscopy 161Specimen Handling 134enzalutamide 125Nivolumab 118Gemcitabine 96Docetaxel 92Radiosurgery 91Prednisone 81Androgen Antagonists 81Abiraterone Acetate 79Radiotherapy 75apalutamide 66Cisplatin 65darolutamide 62Ipilimumab 61Biopsy 61abiraterone 57cabozantinib 55Carboplatin 55Leuprolide 52enfortumab vedotin 50Radiation 47Pluvicto 45Standard of Care 44atezolizumab 41Surveys and Questionnaires 38acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 37X-Rays 37avelumab 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Electroporation × Genitourinary × 1 year × Clear all
NCT07623941 2026-06-03

CUIMC Focal Therapy Registry

Columbia University

Recruiting
1,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT04972097 2026-06-02

PRESERVE

Angiodynamics, Inc.

Phase NA Completed
121 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT05345444 2026-03-25

RTIRE

Weill Medical College of Cornell University

Phase NA Active not recruiting
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT06451445 2025-12-11

WIRED

University Health Network, Toronto

Phase NA Recruiting
100 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡